跳至主要内容
临床试验/IRCT2016012414477N3
IRCT2016012414477N3已完成2 期

the effect of Ginkgo biloba on sexual dysfunction in women with breast cancer compared with placebo

Mashhad University of Medical Sciences, Vice chancellor for research0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
Female

入选标准

  • Being married;18 years of age or older; At least 2 month after the end of treatment; Signed and dated written informed consent prior to admission to the study;The ability to speak; understand the Persian; Patients who had undergone breast cancer surgery
  • Exclusion criteria:
  • not having sex at least twice during the study period; Having any other medical; conditions such as:
  • cardiovascular diseases ( i.e. uncontrolled hypertension, history of infarction, deep-vein thrombosis), Pulmonary diseases (i.e. asthma, shortness of breath), Neurological diseases ( i.e. convulsions, epilepsy, migraine, cerebrovascular disorder), History of bleeding disorder, kidney diseases, liver diseases, endocrine disorders (i.e. diabetes), mental disorders, coagulation disorders; Other malignancies other than breast cancer;Infertility; Stressful event (other than cancer) during the last 6 months (e.g. traumatic and stressful event, changes in living conditions such as relocation, financial ruin, marital problems, losing a close family member); Failing to follow the treatment plan; A history of psychiatric disorder; Patients taking SSRI 2 weeks prior to study; Anticoagulant therapy (Heparin, enoxaparin, warfarin, clopidogrel, ticlopidine) 2 weeks prior to study; Patients with hormone-receptor (HR)-positive breast cancer.

排除标准

  • 未提供

研究者

发起方
Mashhad University of Medical Sciences, Vice chancellor for research

相似试验